CoChat

Intratumoral Hypoxia Reduces IFN-γ–Mediated Immunity and MHC Class I Induction in a Preclinical Tumor Model

Open access

The DOI matches its Crossref record; 49 of the 50 references it cites were found in a registry or an index.

Abstract

Tumor hypoxia occurs because of an increased demand for oxygen by the rapidly growing tumor cells, together with reduction in the oxygen supply due to malformed and nonfunctional tumor vasculature. The effects of tumor hypoxia on radiotherapy (RT) are well known; however, recent findings suggest it may also suppress immunotherapy, although the mechanisms governing this observation remain undetermined. Our laboratory and others have shown that IFN-γ conditions the tumor milieu and is important for the efficacy of RT. Thus, we hypothesized that hypoxia could inhibit IFN-γ–mediated antitumor responses, resulting in decreased RT efficacy. This inhibition could involve the production and/or the cellular response to IFN-γ. To test this, we used murine tumor cell lines B16F0 and Colon38. We observed that hypoxia inhibited upregulation of IFN-γ–dependent MHC class I expression by tumor cells along with the gene expression of IFN-γ–dependent chemokines CXCL9 and CXCL10, essential for immune cell infiltration. Furthermore, CD8+ T cells, an important source of IFN-γ, which mediate effector antitumor responses, had reduced ability to proliferate and generate IFN-γ under hypoxic conditions in vitro. Interestingly, reoxygenation restored the cytokine-producing capability of these cells. Studies performed in vivo using a mouse tumor model and the hypoxia marker EF5 demonstrated that RT could reverse the hypoxia within treated tumors. This study has identified a unique mechanism of hypoxia-induced immune suppression involving the downregulation of IFN-γ production and cellular responsiveness to this essential cytokine. These results suggest that therapies that target and reduce tumor hypoxia can potentially boost antitumor immune responses.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.4049/immunohorizons.1900017

Cites

49 of 49 references verified0 citation errors · 0 not checkable

Statistics

Figures

FIGURE 1. EF5 staining in Colon38 tumors demonstrates hypoxic regions adjacent to CD31+ vessels. Representative fluorescent immunohistochemistry images from a Colon38 tumor. Eleven days after tumor inoculation, tumors were harvested, and 100-μm sections were prepared, fixed, and stained with (A) anti-CD31 (tumor vessels, green) and (B) anti-EF5 ELK-Cy3 (tumor hypoxia, red) Abs. (C) Merged images of vessels and hypoxia. Scale bar, 500 μm (n = 6).
FIGURE 1. EF5 staining in Colon38 tumors demonstrates hypoxic regions adjacent to CD31+ vessels. Representative fluorescent immunohistochemistry images from a Colon38 tumor. Eleven days after tumor inoculation, tumors were harvested, and 100-μm sections were prepared, fixed, and stained with (A) anti-CD31 (tumor vessels, green) and (B) anti-EF5 ELK-Cy3 (tumor hypoxia, red) Abs. (C) Merged images of vessels and hypoxia. Scale bar, 500 μm (n = 6).CC BY-NC · PubMed Central
FIGURE 2. Hypoxia downregulates MHC I expression on tumor cells. Surface expression of MHC I proteins. (A) Murine B16 melanoma tumor cells were stimulated with either IFN-γ or vehicle followed by hypoxic treatment for 16 (left panel) and 48 (right panel) h. Representative histograms from one of three similar experiments. MFI of vehicle-treated tumor cells represented by solid dark line (normoxic) and dotted line (hypoxic condition). IFN-γ–stimulated tumor cells represented by solid gray (normoxic) and long dashes (hypoxic treatment). (B) Surface expression of MHC I proteins on B16 melanoma tumor cells stimulated with IFN-γ followed by normoxic (circles) and hypoxic (squares) treatment for 16, 24, and 48 h. (C) Surface expression of basal level MHC I proteins on Colon38 tumor cells following normoxic (circles) and hypoxic (squares) treatment for 6, 12, 24, and 48 h. Hypoxic = 0.5% O2; normoxic = 21% O2. Line graphs represent an average of three experiments (n = 3). Error bars depict ±SEM. Differences between means of vehicle or IFN-γ–stimulated groups over time were evaluated using two-way ANOVA. *p < 0.05.
FIGURE 2. Hypoxia downregulates MHC I expression on tumor cells. Surface expression of MHC I proteins. (A) Murine B16 melanoma tumor cells were stimulated with either IFN-γ or vehicle followed by hypoxic treatment for 16 (left panel) and 48 (right panel) h. Representative histograms from one of three similar experiments. MFI of vehicle-treated tumor cells represented by solid dark line (normoxic) and dotted line (hypoxic condition). IFN-γ–stimulated tumor cells represented by solid gray (normoxic) and long dashes (hypoxic treatment). (B) Surface expression of MHC I proteins on B16 melanoma tumor cells stimulated with IFN-γ followed by normoxic (circles) and hypoxic (squares) treatment for 16, 24, and 48 h. (C) Surface expression of basal level MHC I proteins on Colon38 tumor cells following normoxic (circles) and hypoxic (squares) treatment for 6, 12, 24, and 48 h. Hypoxic = 0.5% O2; normoxic = 21% O2. Line graphs represent an average of three experiments (n = 3). Error bars depict ±SEM. Differences between means of vehicle or IFN-γ–stimulated groups over time were evaluated using two-way ANOVA. *p < 0.05.CC BY-NC · PubMed Central
FIGURE 3. Hypoxia inhibits IFN-γ–stimulated gene expression in mouse tumor cells. Expression of IFN-γ–stimulated genes in Colon38 tumor cells. (A–D) mRNA levels of (A) PHD-3 and IFN-γ–stimulated genes (B) CXCL10, (C) CXCL9, and (D) IDO were analyzed using quantitative RT-PCR (qRT-PCR) following stimulation of Colon38 tumor cells with IFN-γ or vehicle control and incubated under hypoxic and normoxic conditions for 6 h. All genes were normalized to GAPDH and compared with a normoxic untreated sample. Bar graphs represent an average of three experiments (n = 3). Error bars depict ±SEM. Differences between means of vehicle or IFN-γ–stimulated groups were evaluated using Kruskal–Wallis test. **p < 0.01, ***p < 0.001. (E) Colon38 tumor cells were transfected with small interfering RNA against HIF-1α (siHIF1α) or nonbinding control sequence (siCon), stimulated with IFN-γ or vehicle control, and incubated under hypoxic conditions for 3 h. The mRNA levels of the IFN-γ–stimulated gene IDO was analyzed using qRT-PCR. Values were normalized to GAPDH and compared with a normoxic untreated sample. Three replicate experiments were performed. Error bars depict ±SEM.
FIGURE 3. Hypoxia inhibits IFN-γ–stimulated gene expression in mouse tumor cells. Expression of IFN-γ–stimulated genes in Colon38 tumor cells. (A–D) mRNA levels of (A) PHD-3 and IFN-γ–stimulated genes (B) CXCL10, (C) CXCL9, and (D) IDO were analyzed using quantitative RT-PCR (qRT-PCR) following stimulation of Colon38 tumor cells with IFN-γ or vehicle control and incubated under hypoxic and normoxic conditions for 6 h. All genes were normalized to GAPDH and compared with a normoxic untreated sample. Bar graphs represent an average of three experiments (n = 3). Error bars depict ±SEM. Differences between means of vehicle or IFN-γ–stimulated groups were evaluated using Kruskal–Wallis test. **p < 0.01, ***p < 0.001. (E) Colon38 tumor cells were transfected with small interfering RNA against HIF-1α (siHIF1α) or nonbinding control sequence (siCon), stimulated with IFN-γ or vehicle control, and incubated under hypoxic conditions for 3 h. The mRNA levels of the IFN-γ–stimulated gene IDO was analyzed using qRT-PCR. Values were normalized to GAPDH and compared with a normoxic untreated sample. Three replicate experiments were performed. Error bars depict ±SEM.CC BY-NC · PubMed Central
FIGURE 4. Hypoxic Ag-specific CD8+ T cells are less functional and less proliferative. Effect of hypoxia on CD8+ T cells. (A) Quantification of CD8+ T cell distribution in hypoxic (ELK-Cy3+) or normoxic (ELK-Cy3−) Colon38 tumor samples. Fluorescent immunohistochemistry images from tumor-bearing mice (day 11 after tumor inoculation) were labeled with anti-CD8 and ELK-Cy3 Abs. Using these images, CD8+ T cell densities were calculated. Each dot represents one tumor section; three to eight sections were analyzed per tumor (one tumor per mouse). Circles and squares represent CD8+ T cell density in normoxic (n = 17) areas and hypoxic areas (n = 8), respectively. Error bars depict ±SEM. Differences between means were analyzed using an unpaired t test. p = 0.2793. (B) A total of 5 × 106 OT-1 splenic and lymph node cells were stimulated with SIINFEKL at a concentration of 12.5 mg/ml for 24 h. Following antigenic stimulation, cells were incubated under hypoxic (0.5% O2) or normoxic (21% O2) conditions for another 24 h. Cells were surface-stained for CD45 and CD8 and fixed, and intracellular cytokine IFN-γ was analyzed using flow cytometry. Representative dot plot images (left). Bar graphs (right) represent an average of three experiments (n = 3). Error bars depict ±SEM. Differences between means were analyzed using a Mann–Whitney U test. **p < 0.01. (C) Cell Trace Violet (CTV)–labeled cells were stimulated with OVA peptide fragment (SIINFEKL) at a concentration of 12.5 μg/ml for 24 h. Following antigenic stimulation, OT-1 cells were incubated under hypoxic (0.5% O2) or normoxic (21% O2) conditions for another 24 h. Cells were surface-stained for CD45 and CD8 and fixed, and CTV fluorescence was analyzed using flow cytometry. Representative histograms from one of three similar experiments. (D) A total of 5 × 106 OT-1 splenic and lymph node cells were stimulated with SIINFEKL at a concentration of 12.5 μg/ml for 24 h. Following antigenic stimulation, cells were incubated under hypoxic (0.5% O2) or normoxic (21% O2) conditions for 0, 16, 26, and 44 h. One set of hypoxic (26 h) cells was reoxygenated at 16 h, and the culture continued under normoxic (21% O2) conditions. Cells were surface-stained for CD45 and CD8 and fixed, and intracellular cytokine IFN-γ was analyzed using flow cytometry. Line graphs represent an average of three experiments (n = 3). Error bars depict ±SEM. Means were compared using ordinary two-way ANOVA. *p < 0.05, **p < 0.01.
FIGURE 4. Hypoxic Ag-specific CD8+ T cells are less functional and less proliferative. Effect of hypoxia on CD8+ T cells. (A) Quantification of CD8+ T cell distribution in hypoxic (ELK-Cy3+) or normoxic (ELK-Cy3−) Colon38 tumor samples. Fluorescent immunohistochemistry images from tumor-bearing mice (day 11 after tumor inoculation) were labeled with anti-CD8 and ELK-Cy3 Abs. Using these images, CD8+ T cell densities were calculated. Each dot represents one tumor section; three to eight sections were analyzed per tumor (one tumor per mouse). Circles and squares represent CD8+ T cell density in normoxic (n = 17) areas and hypoxic areas (n = 8), respectively. Error bars depict ±SEM. Differences between means were analyzed using an unpaired t test. p = 0.2793. (B) A total of 5 × 106 OT-1 splenic and lymph node cells were stimulated with SIINFEKL at a concentration of 12.5 mg/ml for 24 h. Following antigenic stimulation, cells were incubated under hypoxic (0.5% O2) or normoxic (21% O2) conditions for another 24 h. Cells were surface-stained for CD45 and CD8 and fixed, and intracellular cytokine IFN-γ was analyzed using flow cytometry. Representative dot plot images (left). Bar graphs (right) represent an average of three experiments (n = 3). Error bars depict ±SEM. Differences between means were analyzed using a Mann–Whitney U test. **p < 0.01. (C) Cell Trace Violet (CTV)–labeled cells were stimulated with OVA peptide fragment (SIINFEKL) at a concentration of 12.5 μg/ml for 24 h. Following antigenic stimulation, OT-1 cells were incubated under hypoxic (0.5% O2) or normoxic (21% O2) conditions for another 24 h. Cells were surface-stained for CD45 and CD8 and fixed, and CTV fluorescence was analyzed using flow cytometry. Representative histograms from one of three similar experiments. (D) A total of 5 × 106 OT-1 splenic and lymph node cells were stimulated with SIINFEKL at a concentration of 12.5 μg/ml for 24 h. Following antigenic stimulation, cells were incubated under hypoxic (0.5% O2) or normoxic (21% O2) conditions for 0, 16, 26, and 44 h. One set of hypoxic (26 h) cells was reoxygenated at 16 h, and the culture continued under normoxic (21% O2) conditions. Cells were surface-stained for CD45 and CD8 and fixed, and intracellular cytokine IFN-γ was analyzed using flow cytometry. Line graphs represent an average of three experiments (n = 3). Error bars depict ±SEM. Means were compared using ordinary two-way ANOVA. *p < 0.05, **p < 0.01.CC BY-NC · PubMed Central
FIGURE 5. Radiotherapy reduces tumor hypoxia. A total of 1 × 105 Colon38 tumor cells were injected i.m. into the left thighs of C57BL/6 mice. Seven days after tumor inoculation, mice were either treated with 15-Gy local radiation or left untreated. Tumors were harvested 7, 9, and 11 d postinoculation. To measure intratumoral hypoxia, mice were given EF5, the tumors were removed 3 h later, and the dissociated cells were labeled with ELK-3–51-Cy3 Ab and analyzed using flow cytometry. (A) Top panels demonstrate the gating strategy. Dot plot on top left is representative of a mouse that did not receive EF5 and was used as a negative control. (B) Panel represents the ELK-3–51-Cy3+ population referred to as total (tumor and immune cell) hypoxia. Total hypoxia (y-axis) from tumors harvested at the indicated time points was plotted, with each dot representing an individual tumor (one tumor per mouse). Means at each time point were analyzed using ordinary one-way ANOVA. ***p < 0.001, ****p < 0.0001. (n = 5–10). (C) Eleven days after tumor inoculation, tumors were harvested, and 100-μm sections were prepared. Sections were fixed, labeled with ELK-3–51-Cy3, and analyzed using conventional microscopy. Red represents hypoxic areas. Scale bars, 1 mm (untreated), 500 μm (irradiated). Panels depict representative tumor images. Mean EF5/ELK-Cy3 intensity is represented as (D) a function of pixels per square millimeter and (E) a percentage of total area of the section in irradiated and untreated tumor samples. (F) Mean EF5/ELK-Cy3 intensity. Each dot represents a representative section from one tumor per mouse (untreated n = 6; irradiated n = 3). Three to eight sections were analyzed per tumor. Error bars depict ±SEM. Means were compared using Mann–Whitney U test. **p < 0.01.
FIGURE 5. Radiotherapy reduces tumor hypoxia. A total of 1 × 105 Colon38 tumor cells were injected i.m. into the left thighs of C57BL/6 mice. Seven days after tumor inoculation, mice were either treated with 15-Gy local radiation or left untreated. Tumors were harvested 7, 9, and 11 d postinoculation. To measure intratumoral hypoxia, mice were given EF5, the tumors were removed 3 h later, and the dissociated cells were labeled with ELK-3–51-Cy3 Ab and analyzed using flow cytometry. (A) Top panels demonstrate the gating strategy. Dot plot on top left is representative of a mouse that did not receive EF5 and was used as a negative control. (B) Panel represents the ELK-3–51-Cy3+ population referred to as total (tumor and immune cell) hypoxia. Total hypoxia (y-axis) from tumors harvested at the indicated time points was plotted, with each dot representing an individual tumor (one tumor per mouse). Means at each time point were analyzed using ordinary one-way ANOVA. ***p < 0.001, ****p < 0.0001. (n = 5–10). (C) Eleven days after tumor inoculation, tumors were harvested, and 100-μm sections were prepared. Sections were fixed, labeled with ELK-3–51-Cy3, and analyzed using conventional microscopy. Red represents hypoxic areas. Scale bars, 1 mm (untreated), 500 μm (irradiated). Panels depict representative tumor images. Mean EF5/ELK-Cy3 intensity is represented as (D) a function of pixels per square millimeter and (E) a percentage of total area of the section in irradiated and untreated tumor samples. (F) Mean EF5/ELK-Cy3 intensity. Each dot represents a representative section from one tumor per mouse (untreated n = 6; irradiated n = 3). Three to eight sections were analyzed per tumor. Error bars depict ±SEM. Means were compared using Mann–Whitney U test. **p < 0.01.CC BY-NC · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 49 references

Cited by

Metadata

Authors
Murthy, A., Gerber, S. A., Koch, C. J., & Lord, E. M.
Affiliations
  • University of Rochester Medicine (US)
  • University of Pennsylvania (US)
Corresponding author
Murthy, Aditi
Venue
ImmunoHorizons
Published
2019-04-01
Volume
3
Issue
4
Pages
149-160
ISSN
2573-7732 (ISSN-L)
OpenAlex
W2942594871
Cited by
36
References
50
Citations by year
2026: 4 · 2025: 4 · 2024: 3 · 2023: 7 · 2022: 6 · 2021: 7 · 2020: 4 · 2019: 1
FWCI
1.42
Type
journal article
Language
en
Open access
Locations
  • ImmunoHorizons (publishedVersion, cc-by-nc)
  • PubMed (publishedVersion)
  • PubMed Central (acceptedVersion, cc-by-nc)
Funders
National Cancer Institute (R01CA028332)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
  • Health Sciences › Medicine › Oncology › Cancer Immunotherapy and Biomarkers
  • Life Sciences › Immunology and Microbiology › Immunology › Immunotherapy and Immune Responses
Keywords
tumor hypoxia, intratumoral hypoxia, interferon-gamma, MHC class I expression, antitumor immunity, radiotherapy, CD8+ T cells, CXCL9, CXCL10, chemokines, immune cell infiltration, tumor reoxygenation, immunosuppression, B16F0 melanoma, colon cancer cells
MeSH terms
Animals, Hypoxia, Disease Models, Animal, Female, Humans, Immunity, Immunohistochemistry, Interferon-gamma, Male, Neoplasms, Histocompatibility Antigens Class I, Biomarkers, Gene Expression Regulation, Neoplastic, CD8-Positive T-Lymphocytes, T-Cell Antigen Receptor Specificity, Cell Line, Tumor, Mice, Heterografts

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.